SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies establishes pre-clinical proof of concept for DPPC

25 Apr 2012 Evaluate

Venus Remedies has established pre-clinical proof of concept for its Drug-Protein-Polymer-Conjugate (DPPC). DPPC concept is a novel, patent protected technology, which will help in alleviating cancer specific and selective targeting of tumor cells.

The escalating prevalence of cancers of all kinds and the ever rising unmet need in the field of cancer treatment has made Venus to tap a huge market potential in the first year of the DPPC’s launch itself. This technology would bring revolution to the existing target anti-cancer therapies. The company is all geared up to commercially launch this novel triple conjugate therapy hopefully by next 2-3 years.

The company is also contributing successfully in the oncology segment across the globe through its wide array of key products, which includes Docetaxel, Paclitaxel, Gemcitabine, Oxaliplatin, Irinotecan and Topotecan. The company is also focusing on the anti-infective segment which is posing a threat to the mankind worldwide. Venus Medicine Research Centre (VMRC) is putting great efforts to come out with revolutionary drugs to eradicate these deadly infections.

Venus Remedies Share Price

1704.10 0.25 (0.01%)
09-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.85
Dr. Reddys Labs. 1269.80
Cipla 1441.70
Zydus Lifesciences 1159.85
Lupin 2502.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: